Dapagliflozin - AstraZeneca
At a glance
- Drug Originator Bristol-Myers Squibb
- Drug Licenced by AstraZeneca KK; Ono Pharmaceutical; Sun Pharmaceutical Industries
- Drug Class Anti-ischaemics; Antihyperglycaemics; Antivirals; Benzhydryl compounds; Cardiovascular therapies; Chlorobenzenes; Glucosides; Heart failure therapies; Hepatoprotectants; Obesity therapies; Pyrans; Small molecules; Urologics
- Mechanism of Action Sodium-glucose transporter 2 inhibitors
- USA Patent Applicants ASTRAZENECA AB
- USA Patents 45
- NDAs 1
- International Patents 424
- Patent Applications 188
Table of Contents

Disclaimer